71 results
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
Consortium, BMS / Agios Clinical Trial Sites; top affiliated practices include community and academic heme/onc practices in top 5 deciles; 3+ heme/onc visits … and function PYRUKYND Seamless Phase 2/3 global study designed with community input Potential for mitapivat to: improve anemia reduce sickle cell pain
8-K
EX-99.1
5p5hq
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
DEFM14A
g1hhs k9h
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
tmct5rybbidenbs zk1
29 Jan 21
Preliminary proxy related to merger
4:22pm